6-75666723-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_015571.4(SENP6):āc.1006A>Gā(p.Ser336Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000000731 in 1,367,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 7.3e-7 ( 0 hom. )
Consequence
SENP6
NM_015571.4 missense
NM_015571.4 missense
Scores
3
9
7
Clinical Significance
Conservation
PhyloP100: 7.12
Genes affected
SENP6 (HGNC:20944): (SUMO specific peptidase 6) Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1; MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins (Kim et al., 2000 [PubMed 10799485]). SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity SENP6_HUMAN
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SENP6 | NM_015571.4 | c.1006A>G | p.Ser336Gly | missense_variant | 10/24 | ENST00000447266.7 | NP_056386.2 | |
SENP6 | NM_001100409.3 | c.985A>G | p.Ser329Gly | missense_variant | 9/23 | NP_001093879.1 | ||
SENP6 | NM_001304792.2 | c.985A>G | p.Ser329Gly | missense_variant | 9/15 | NP_001291721.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SENP6 | ENST00000447266.7 | c.1006A>G | p.Ser336Gly | missense_variant | 10/24 | 1 | NM_015571.4 | ENSP00000402527.2 | ||
SENP6 | ENST00000370010.6 | c.985A>G | p.Ser329Gly | missense_variant | 9/23 | 1 | ENSP00000359027.2 | |||
SENP6 | ENST00000327284.12 | c.985A>G | p.Ser329Gly | missense_variant | 9/15 | 2 | ENSP00000321820.8 | |||
SENP6 | ENST00000424947.6 | c.676A>G | p.Ser226Gly | missense_variant | 7/13 | 2 | ENSP00000391426.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.31e-7 AC: 1AN: 1367654Hom.: 0 Cov.: 25 AF XY: 0.00000147 AC XY: 1AN XY: 679058
GnomAD4 exome
AF:
AC:
1
AN:
1367654
Hom.:
Cov.:
25
AF XY:
AC XY:
1
AN XY:
679058
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.1006A>G (p.S336G) alteration is located in exon 10 (coding exon 10) of the SENP6 gene. This alteration results from a A to G substitution at nucleotide position 1006, causing the serine (S) at amino acid position 336 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Benign
Sift
Pathogenic
D;D;D;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;D;D;.
Vest4
MutPred
0.15
.;.;Loss of phosphorylation at S336 (P = 0.0134);.;
MVP
MPC
0.49
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 26
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.